Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive function

Abstract Establishing a brain biomarker for schizophrenia is strongly desirable not only to support diagnosis by psychiatrists but also to help track the progressive changes in the brain over the course of the illness. A brain morphological signature of schizophrenia was reported in a recent study a...

Full description

Bibliographic Details
Main Authors: Ryuichi Yamazaki, Junya Matsumoto, Satsuki Ito, Kiyotaka Nemoto, Masaki Fukunaga, Naoki Hashimoto, Fumitoshi Kodaka, Harumasa Takano, Naomi Hasegawa, Yuka Yasuda, Michiko Fujimoto, Hidenaga Yamamori, Yoshiyuki Watanabe, Kenichiro Miura, Ryota Hashimoto
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Neuropsychopharmacology Reports
Subjects:
Online Access:https://doi.org/10.1002/npr2.12423